Estrogen as Treatment for Anorexia Nervosa

About this study

Research Team

Professor Jayashri Kulkarni, Dr Eva Gregertsen, Dr Romi Goldschlager, Dr Eveline Mu

Institution

Monash University

Ethics Approval Number

HREC/100958/Alfred-2023

Funding Source

Philanthropy

Project Start Date

1 April 2024

Project End Date

1 April 2026

Participants

Females aged 16 and over living with anorexia nervosa (including in partial remission and atypical anorexia nervosa)

What is Involved

5 Visits to our research site in Melbourne over a 3 month duration + 1 additional visit 3 months after end of treatment.

Ethics Approval Number

HREC/100958/Alfred-2023

Location

607 St Kilda Road, Melbourne

Contact Details

THRED@monash.edu

The Li-Transformative Hub for Research into Eating Disorders (Li-THRED) at Monash University is conducting a double-blinded randomised controlled trial exploring the effectiveness of estrogen to treat eating disorder symptoms in women with anorexia nervosa. It is hypothesised that estrogen will improve eating disorder symptoms as compared to placebo.


« Back to Browse Resources

See also

Choosing Important Features in an Eating Disorder Clinical Quality Registry

Researchers at UTS want to know what features are important in a Clinical Quality Registry (CQR) for eating disorders.

Read more

Feel Better with Nature: A Daily Life Experience

Researchers from the University of Melbourne are seeking research participants to take part in a multi-part study investigating how spending time in nature influences body image and daily eating patterns.

Read more

A Study of Tiktok Use

This research investigates the degree to which people engage with TikTok videos that focus on appearance, and how exposure to these videos might relate to experiences like body dissatisfaction and eating disorder symptoms over a period of 6 months.

Read more

Health Professionals’ Perspectives on GLP-1 Weight Loss Drugs and Managing Users' Needs and Expectations

Dear Colleagues, We would like to invite you take part in a study being conducted through the School of Health at the University of the Sunshine Coast, aimed at exploring health professionals' diverse perspectives on the use of GLP-1 drugs for weight management.

Read more